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Review question(s)
To evaluate current literature on non-pharmacological interventions for promoting sleep in non-remissive cancer
patients.
Searches
Studies were extracted from electronic databases, last searched on 11 November 2014, including: EMBASE
(1996-present), MEDLINE (1996-present), PsycINFO (2002-present) via the OvidSP platform, and CINAHL
(1981-present) via the EBSCO platform. Other reviews were scanned for studies that were eligible. No authors
needed to be contacted for information. 
Variations and expansions on terms such as: ‘neoplasms’, ‘group interventions’, and ‘sleep promotion’, were used to
search the databases. See Appendix A for the full search strategy. 
Studies with a sample size <50 were excluded. Foreign-language, conference papers or theses were excluded. No
stipulations were made as to year of publication. The studies included had follow-up periods of any duration.
Types of study to be included
Included studies were quantitative and randomised, reducing possible confounding factors on intervention efficacy or
outcome measures.
Condition or domain being studied
Sleep disturbance engenders physiological and psychological problems. Literature demonstrates sleep disturbance a
co-symptom of concurrent cancer. There is no agreement on the best non-invasive, drug-free interventions for
improving sleep quality in this population.
Participants/ population
Included studies had participants from any demographic background with a diagnosis of cancer of any stage/variety,
but excluded if participants were in complete remission.
Intervention(s), exposure(s)
Included studies had non-pharmacological, and/or non-invasive sleep-related interventions of any duration.
Comparator(s)/ control
Included studies compared a sleep-related intervention and an alternative/control intervention, or no intervention.
Context
None were excluded on the basis of setting; depending on the intervention and outcome measure, different locations
were necessary or practical.
Outcome(s)
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Primary outcomes
Studies were included if they had outcome measures related to sleep quality, quantity and/or problems.
Secondary outcomes
None
Data extraction, (selection and coding)
Assessment of eligibility was performed by two non-blinded reviewers. The first stage involved abstract and title
screening. Abstract/title screening removed duplicates, studies without cancer patients (or patients in remission),
studies without any non-pharmacologic intervention or no sleep-related measure. Remaining studies were inspected
further, using full-text screening as appropriate. This stage excluded non-randomised studies and those with a sample
size <50. This was conducted by both reviewers side-by-side, ensuring agreement and open discussion. 
Details extracted included information about the authors, title, year and country of publication, aims, setting and study
design, and type/data (at every measurement point) for all primary and secondary outcome measures. Key
demographic information was noted, including the number, age, sex and type of cancer of the participants. Any
additional demographic information reported also, typically educational achievement, race, and type of previous
treatments. Study participant inclusion/exclusion criteria were outlined. The intervention name, type, duration and
details provided by the authors were outlined. If applicable, details of the control groups, whether they received
control interventions or not, were extracted.
Risk of bias (quality) assessment
An adapted Cochrane Collaboration risk-of-bias tool was used to assess five categories of bias. 
The first related to ‘selection bias’ (biased allocation to interventions), including one subcategory concerning the
method by which the randomisation sequence was generated - assessing whether the randomisation was truly random,
and a second assessing allocation concealment - whether the sequence was concealed from investigators before and
until condition assignment. 
The second main category related to ‘performance bias’: whether the authors/researchers and participants were blind
to the allocated conditions. Importantly, knowledge of the condition may alter intervention efficacy via expectancy
effects. Studies were often face-to-face therapies, involving the researchers implementing their intervention, thus
knowing condition assignment. This was not allowed for; the risk-of-bias was still present and adjudged
appropriately. 
The third was ‘detection bias’ - judging whether participants’ data was analysed by researchers blinded to conditions,
eliminating any researcher-based inflation of effects. 
The fourth was ‘attrition bias.’ Studies had participants drop-out, or excluded, for various reasons (deaths, or found
ineligible at a later date) - potentially creating non-comparable conditions. Reasoning for participant removal and
statistical methods to account for missing data were assessed for transparency, and any biases detected.
Lastly, ‘selective reporting’ was judged, assessing whether studies published results that suited their pre-conceptions,
or had missing data. Each category was judged as high, medium or low-risk. Cochrane reviews do not have ‘medium’
but include an ‘unclear’ judgment. ‘Medium’ was felt to be an important distinction, whereby studies made an effort to
address an issue of bias, but not adequately. Because of the seriousness of the subject matter an ‘unclear’ bias was
typically judged to be ‘medium’ – as a conservative and stringent way of highlighting a potential risk. If no effort was
made to address an aspect of bias, it was automatically ‘high-risk.’
Strategy for data synthesis
Results of the studies were synthesised narratively describing categorical intervention type, delivery and duration
efficacy.
Analysis of subgroups or subsets
Intervention efficacy moderated by demographics and outcome measures was assessed.
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Dissemination plans
We aim to publish this review in a a high impact journal. We will work with our university press office and patient
and provider networks as advised by our RDSU and CLAHRC YH.
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